Search research articles
Contact Us
Filters
Showing results (161-170 of 187) with videos related to
Page
of 19
Sort By:
The Journal of Pharmacology and Experimental Therapeutics
|
October 22, 2009
Influence of cyclooxygenase inhibitors on the function of the prostaglandin transporter organic anion-transporting polypeptide 2A1 expressed in human gastroduodenal mucosa
Kathrin Mandery, Krystyna Bujok, Ingrid Schmidt, et al.
EJNMMI Research
|
September 4, 2024
Heteroaryl derivatives of suvorexant as OX1R selective PET ligand candidates: Cu-mediated <sup>18</sup>F-fluorination of boroxines, in vitro and initial in vivo evaluation
Kim-Viktoria Bolik, Jan Hellmann, Simone Maschauer, et al.
European Journal of Clinical Pharmacology
|
December 18, 2007
The association of ABCB1 polymorphisms and elevated serum digitoxin concentrations in geriatric patients
Charalampos Dragonas, Jan T Wagner, Hans J Heppner, et al.
British Journal of Clinical Pharmacology
|
November 8, 2024
Physicians' and pharmacists' perspective on clarity and clinical relevance of absolute contraindications in "Summaries of Product Characteristics"
Wahram Andrikyan, Michael I Sponfeldner, Lea Jung-Poppe, et al.
Scientific Reports
|
December 5, 2025
Metabolomic and immunophenotypic signatures in cerebral amyloid angiopathy: a pilot study
Thanos Tsaktanis, Arne Gessner, Steffen Pfeuffer, et al.
Pharmacogenetics
|
July 1, 2004
High plasma pravastatin concentrations are associated with single nucleotide polymorphisms and haplotypes of organic anion transporting polypeptide-C (OATP-C, SLCO1B1)
Mikko Niemi, Elke Schaeffeler, Thomas Lang, et al.
Clinical Pharmacology and Therapeutics
|
May 9, 2006
Effects of ursodeoxycholic acid on P-glycoprotein and cytochrome P450 3A4-dependent pharmacokinetics in humans
Laurent Becquemont, Hartmut Glaeser, Siegfried Drescher, et al.
Cancers
|
December 24, 2021
An Easily Expandable Multi-Drug LC-MS Assay for the Simultaneous Quantification of 57 Oral Antitumor Drugs in Human Plasma
Niklas Kehl, Katja Schlichtig, Pauline Dürr, et al.
Journal of the American College of Cardiology
|
May 17, 2008
Cytochrome P450 2C19 681G>A polymorphism and high on-clopidogrel platelet reactivity associated with adverse 1-year clinical outcome of elective percutaneous coronary intervention with drug-eluting or bare-metal stents
Dietmar Trenk, Willibald Hochholzer, Martin F Fromm, et al.
Clinical Pharmacology and Therapeutics
|
November 12, 2002
Modulation of steady-state kinetics of digoxin by haplotypes of the P-glycoprotein MDR1 gene
Andreas Johne, Karla Köpke, Thomas Gerloff, et al.
Page
of 19
Search research articles
Search
Showing results (161-170 of 187) with videos related to
Sort By:
Page
of 19
The Journal of Pharmacology and Experimental Therapeutics
|
October 22, 2009
Influence of cyclooxygenase inhibitors on the function of the prostaglandin transporter organic anion-transporting polypeptide 2A1 expressed in human gastroduodenal mucosa
Kathrin Mandery, Krystyna Bujok, Ingrid Schmidt, et al.
EJNMMI Research
|
September 4, 2024
Heteroaryl derivatives of suvorexant as OX1R selective PET ligand candidates: Cu-mediated <sup>18</sup>F-fluorination of boroxines, in vitro and initial in vivo evaluation
Kim-Viktoria Bolik, Jan Hellmann, Simone Maschauer, et al.
European Journal of Clinical Pharmacology
|
December 18, 2007
The association of ABCB1 polymorphisms and elevated serum digitoxin concentrations in geriatric patients
Charalampos Dragonas, Jan T Wagner, Hans J Heppner, et al.
British Journal of Clinical Pharmacology
|
November 8, 2024
Physicians' and pharmacists' perspective on clarity and clinical relevance of absolute contraindications in "Summaries of Product Characteristics"
Wahram Andrikyan, Michael I Sponfeldner, Lea Jung-Poppe, et al.
Scientific Reports
|
December 5, 2025
Metabolomic and immunophenotypic signatures in cerebral amyloid angiopathy: a pilot study
Thanos Tsaktanis, Arne Gessner, Steffen Pfeuffer, et al.
Pharmacogenetics
|
July 1, 2004
High plasma pravastatin concentrations are associated with single nucleotide polymorphisms and haplotypes of organic anion transporting polypeptide-C (OATP-C, SLCO1B1)
Mikko Niemi, Elke Schaeffeler, Thomas Lang, et al.
Clinical Pharmacology and Therapeutics
|
May 9, 2006
Effects of ursodeoxycholic acid on P-glycoprotein and cytochrome P450 3A4-dependent pharmacokinetics in humans
Laurent Becquemont, Hartmut Glaeser, Siegfried Drescher, et al.
Cancers
|
December 24, 2021
An Easily Expandable Multi-Drug LC-MS Assay for the Simultaneous Quantification of 57 Oral Antitumor Drugs in Human Plasma
Niklas Kehl, Katja Schlichtig, Pauline Dürr, et al.
Journal of the American College of Cardiology
|
May 17, 2008
Cytochrome P450 2C19 681G>A polymorphism and high on-clopidogrel platelet reactivity associated with adverse 1-year clinical outcome of elective percutaneous coronary intervention with drug-eluting or bare-metal stents
Dietmar Trenk, Willibald Hochholzer, Martin F Fromm, et al.
Clinical Pharmacology and Therapeutics
|
November 12, 2002
Modulation of steady-state kinetics of digoxin by haplotypes of the P-glycoprotein MDR1 gene
Andreas Johne, Karla Köpke, Thomas Gerloff, et al.
Page
of 19